miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression

Author:

Zou Zhenyou12,Zou Ruyi3,Zong Dan1,Shi Yonghong4,Chen Jinyao5,Huang Jie1,Zhu Jiahui1,Chen Liguan1,Bao Xiaoyan1,Liu Yuan1,Liu Weihao1,Huang Wenhui1,Hu Jingsang1,Chen Zhi1,Lao Xiaojie1,Chen Chaoqun1,Huang Xiaoli1,Lu Yao1,Ni Xueyin1,Fang Daoquan1,Wu Dengqiang1,Lu Shuangshuang1,Jiang Mingzhu1,Qiu Chenyang1,Wu Yuya1,Qiu Qisha1,Dong Yanyuan1,Su Yangyang1,Zhao Chenmin1,Zhong Zhihe1,Cai Jing1,Liang Yong1

Affiliation:

1. Tumor Institute; Taizhou University; Taizhou ZJ China

2. Biochemistry Department of Purdue University; West Lafayette IN USA

3. Chemistry Department of Shangrao Normal University; Shangrao JX China

4. Life science College of Nanjing Agricultural University; Nanjing JS China

5. Radiology Department of Taizhou Hospital; Taizhou ZJ China

Funder

Zhejiang Provincial Nature and Science Fund

Public Welfare Technology Research Grant for Zhejiang Social Development

Taizhou University Research Fund

Taizhou University Talent Fostering Fund

Tumor Institute of Taizhou University

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Reference47 articles.

1. American Cancer Society, Inc Cancer Facts & Figures 2012

2. Cancer multidrug resistance progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments;Nat Biotechnol,2000

3. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans;Morschhauser;PLoS Pathog,2007

4. Clinical significance of multi-drug resistance associated protein and P-glycoprotein in patients with bladder cancer;Masayuki;J Urol,1997

5. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil;Tsuruo;Cancer Res,1981

Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3